Zoetis Shares Outstanding 2011-2020 | ZTS

Zoetis shares outstanding history from 2011 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Zoetis shares outstanding for the quarter ending March 31, 2020 were 0.479B, a 0.85% decline year-over-year.
  • Zoetis 2019 shares outstanding were 0.482B, a 1.05% decline from 2018.
  • Zoetis 2018 shares outstanding were 0.487B, a 1.27% decline from 2017.
  • Zoetis 2017 shares outstanding were 0.493B, a 1.02% decline from 2016.
Zoetis Annual Shares Outstanding
(Millions of Shares)
2019 482
2018 487
2017 493
2016 498
2015 502
2014 502
2013 500
2012 500
2011 500
2010 500
Zoetis Quarterly Shares Outstanding
(Millions of Shares)
2020-03-31 479
2019-12-31 482
2019-09-30 482
2019-06-30 482
2019-03-31 483
2018-12-31 487
2018-09-30 486
2018-06-30 488
2018-03-31 490
2017-12-31 493
2017-09-30 492
2017-06-30 494
2017-03-31 495
2016-12-31 498
2016-09-30 498
2016-06-30 499
2016-03-31 500
2015-12-31 502
2015-09-30 502
2015-06-30 500
2015-03-31 503
2014-12-31 502
2014-09-30 502
2014-06-30 502
2014-03-31 501
2013-12-31 500
2013-09-30 500
2013-06-30 500
2013-03-31 500
2012-12-31 500
2012-09-30 500
2012-06-30 500
2012-03-31 500
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $61.795B $6.260B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $59.682B 10.46
Astellas Pharma (ALPMY) Japan $30.032B 15.00
Eisai (ESALY) Japan $20.944B 39.02
UCB SA (UCBJF) Belgium $17.183B 0.00
Merck (MKGAF) Germany $14.504B 19.02
Grifols, S.A (GRFS) Spain $14.170B 17.61
Catalent (CTLT) United States $12.163B 47.02
Neurocrine Biosciences (NBIX) United States $11.590B 53.56
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.633B 0.00
Ionis Pharmaceuticals (IONS) United States $7.589B 40.35
Orion OYJ (ORINY) Finland $6.879B 30.82
IPSEN SA ADR (IPSEY) France $6.412B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.064B 9.71
United Therapeutics (UTHR) United States $5.175B 9.81
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Nektar Therapeutics (NKTR) United States $4.101B 0.00
Evotec AG (EVTCY) Germany $3.888B 62.70
ChemoCentryx (CCXI) United States $3.728B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.632B 396.56
FibroGen (FGEN) United States $3.281B 0.00
PTC Therapeutics (PTCT) United States $3.182B 0.00
Hypermarcas (HYPMY) Brazil $3.153B 9.59
Taro Pharmaceutical Industries (TARO) Israel $2.643B 10.86
Sage Therapeutics (SAGE) United States $2.022B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.908B 14.60
Pacira BioSciences (PCRX) United States $1.900B 38.88
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.824B 0.00
Corcept Therapeutics (CORT) United States $1.805B 17.90
Xencor (XNCR) United States $1.796B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.727B 0.00
USANA Health Sciences (USNA) United States $1.706B 17.49
Zogenix (ZGNX) United States $1.659B 0.00
Heron Therapeutics (HRTX) United States $1.653B 0.00
Akebia Therapeutics (AKBA) United States $1.584B 0.00
Karyopharm Therapeutics (KPTI) United States $1.510B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.404B 15.13
Portola Pharmaceuticals (PTLA) United States $1.399B 0.00
Indivior (INVVY) United States $1.399B 17.36
Translate Bio (TBIO) United States $1.286B 0.00
Tilray (TLRY) Canada $1.279B 0.00
Esperion Therapeutics (ESPR) United States $1.202B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.151B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.106B 49.38
ImmunoGen (IMGN) United States $0.896B 0.00
Endo (ENDP) Ireland $0.887B 1.37
BioCryst Pharmaceuticals (BCRX) United States $0.841B 0.00
Collegium Pharmaceutical (COLL) United States $0.773B 0.00
Molecular Templates (MTEM) United States $0.736B 0.00
Aerie Pharmaceuticals (AERI) United States $0.731B 0.00
Ardelyx (ARDX) United States $0.699B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.603B 0.00
Radius Health (RDUS) United States $0.590B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.584B 0.00
Harpoon Therapeutics (HARP) United States $0.570B 0.00
Innate Pharma SA (IPHYF) France $0.555B 0.00
Trillium Therapeutics (TRIL) Canada $0.528B 0.00
Siga Technologies (SIGA) United States $0.486B 0.00
DURECT (DRRX) United States $0.484B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.457B 11.05
Calithera Biosciences (CALA) United States $0.442B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.425B 16.60
Ocular Therapeutix (OCUL) United States $0.385B 0.00
Flexion Therapeutics (FLXN) United States $0.377B 0.00
MEI Pharma (MEIP) United States $0.372B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.360B 0.00
Organogenesis Holdings (ORGO) United States $0.354B 0.00
TherapeuticsMD (TXMD) United States $0.340B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.324B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.307B 0.00
Concert Pharmaceuticals (CNCE) United States $0.300B 0.00
Lannett Co Inc (LCI) United States $0.298B 6.54
Oasmia Pharmaceutical AB (OASMY) Sweden $0.293B 0.00
CASI Pharmaceuticals (CASI) United States $0.271B 0.00
Redhill Biopharma (RDHL) Israel $0.260B 0.00
Rafael Holdings (RFL) United States $0.241B 0.00
Xeris Pharmaceuticals (XERS) United States $0.218B 0.00
VAXART, INC (VXRT) United States $0.216B 0.00
IMV INC (IMV) Canada $0.211B 0.00
OptiNose (OPTN) United States $0.211B 0.00
KalVista Pharmaceuticals (KALV) United States $0.202B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.197B 0.00
Taiwan Liposome (TLC) Taiwan $0.194B 0.00
Aquestive Therapeutics (AQST) United States $0.193B 0.00
Jounce Therapeutics (JNCE) United States $0.192B 4.59
PROFOUND MEDICL (PROF) Canada $0.191B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 22.85
Summit Therapeutics (SMMT) United Kingdom $0.133B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.128B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.123B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.123B 0.00
Recro Pharma (REPH) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.110B 0.00
PharmAthene (ALT) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
CV Sciences (CVSI) United States $0.094B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.092B 0.00
Sundial Growers (SNDL) Canada $0.091B 0.00
SCYNEXIS (SCYX) United States $0.078B 0.00
CTI BioPharma (CTIC) United States $0.077B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Heat Biologics (HTBX) United States $0.071B 0.00
Onconova Therapeutics (ONTX) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.067B 0.00
Biomerica (BMRA) United States $0.066B 0.00
Nivalis Therapeutics (ALPN) United States $0.063B 0.00
RENEURON GP (RNUGF) United Kingdom $0.060B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
MediWound (MDWD) Israel $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.054B 32.18
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.052B 0.00
Aclaris Therapeutics (ACRS) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 102.54
Lipocine (LPCN) United States $0.047B 0.00
GTx (ONCT) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.044B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.039B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.035B 0.00
PolarityTE (PTE) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Mannatechorporated (MTEX) United States $0.033B 6.33
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Cardiome Pharma (CORV) Canada $0.028B 0.00
Jaguar Animal Health (JAGX) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Novan (NOVN) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00